Name
RABIES IMMUNOGLOBULIN
Mode of Action
IT PROVIDES PASSIVE PROTECTION WHEN GIVEN IMMIDIATELY TO INDIVIDUALS EXPOSED TO RABIES VIRUS. THIS PROVIDES MAXIMUM CIRCULATING ANTIBODIES WITH MINIMUM INTERFERENCE OF ACTIVE IMMUNIZATION WITH HUMAN DIPLOID CELL VACCINE WHICH IS USED IN CONJUNCTION AS PART OF THE POSTEXPOSURE TREATMENT FOR THE PREVENTION OF RABIES IN PREVIOUSLY UNIMMUNISED PERSON WHO HAS BEEN BITTEN BY RABID ANIMAL.
Dosage
RECOMMENDED DOSE - 20 I.U./KG,UPTO HALF OF WHICH SHOULD BE INFILTRATED AROUND THE WOUND AND REMAINDER BEING GIVEN I.M. AT A DIFFERENT SITE TO WHICH THE VACCINE HAS BEEN GIVEN.
Drug Group
[IMMUNOGLOBULIN]
Cross Reaction
VACCINE SUCH AS MEASLES, MUMPS, POLIO, CHICKEN POX AND REBELLA SHOULD BE USED AFTER 3 MONTHS OF TETANUS IMMUNE GLOBULIN ADMINISTRATION SINCE ANTIBODIES IN IMMUNE GLUBULIN PREPARATIONS MAY INTERFERE WITH PATIENT RESPONSES TO LIVE VACCINES.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph